donna j.
Thu Oct 13, 2011, 06:33 PM
http://www.marketwatch.com/story/telik-announces-initiation-of-a-phase-2b-clinical-trial-of-telintra-ezatiostat-hcl-in-patients-with-low-to-intermediate-1-risk-non-deletion-5q-myelodysplastic-syndrome-2011-10-13
New information just received on my home page. May be beneficial for one of us out there.
New information just received on my home page. May be beneficial for one of us out there.